BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Inflammation-Based Prognostic System Predicts Postoperative Survival of Colorectal Cancer Patients with a Normal Preoperative Serum Level of Carcinoembryonic Antigen. Ann Surg Oncol 2012;19:3422-31. [DOI: 10.1245/s10434-012-2384-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Park EJ, Baik SH, Kang J, Hur H, Min BS, Lee KY, Kim NK. The Impact of Postoperative Complications on Long-term Oncologic Outcomes After Laparoscopic Low Anterior Resection for Rectal Cancer. Medicine (Baltimore) 2016;95:e3271. [PMID: 27057884 DOI: 10.1097/MD.0000000000003271] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
2 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
3 Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. J Cancer Res Clin Oncol 2013;139:1449-55. [DOI: 10.1007/s00432-013-1459-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534-540. [PMID: 22995477 DOI: 10.1016/j.ctrv.2012.08.003] [Cited by in Crossref: 633] [Cited by in F6Publishing: 635] [Article Influence: 63.3] [Reference Citation Analysis]
5 Hachiya H, Ishizuka M, Takagi K, Iwasaki Y, Shibuya N, Nishi Y, Aoki T, Kubota K. Clinical significance of the globulin-to-albumin ratio for prediction of postoperative survival in patients with colorectal cancer. Ann Gastroenterol Surg 2018;2:434-41. [PMID: 30460347 DOI: 10.1002/ags3.12201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Okimoto S, Kobayashi T, Tashiro H, Kuroda S, Ishiyama K, Ide K, Abe T, Hashimoto M, Iwako H, Hamaoka M, Honmyo N, Yamaguchi M, Ohdan H. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis. Int J Surg 2017;42:209-14. [PMID: 28483664 DOI: 10.1016/j.ijsu.2017.04.068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lee YJ, Kim WR, Han J, Han YD, Cho MS, Hur H, Lee KY, Kim NK, Min BS. Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer. Ann Coloproctol 2016;32:208-14. [PMID: 28119863 DOI: 10.3393/ac.2016.32.6.208] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
8 Woo HD, Kim K, Kim J. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis. Cancer Causes Control. 2015;26:1661-1670. [PMID: 26376895 DOI: 10.1007/s10552-015-0663-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
9 Yamamoto M, Saito H, Uejima C, Tanio A, Takaya S, Sakamoto T, Honjo S, Maeta Y, Ashida K, Fujiwara Y. Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients. Surg Today 2018;48:986-93. [PMID: 29946884 DOI: 10.1007/s00595-018-1689-9] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
10 Dolan RD, McMillan DC. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score. Crit Rev Oncol Hematol 2020;150:102962. [PMID: 32344318 DOI: 10.1016/j.critrevonc.2020.102962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhou J, Wei W, Hou H, Ning S, Li J, Huang B, Liu K, Zhang L. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer. Front Cell Dev Biol 2021;9:637650. [PMID: 34765598 DOI: 10.3389/fcell.2021.637650] [Reference Citation Analysis]
12 Lv Y, Pan Y, Dong C, Liu P, Zhang C, Xing D. Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients. Med Sci Monit 2017;23:3780-8. [PMID: 28775246 DOI: 10.12659/msm.903710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mcmillan DC, Horgan PG. Preoperative indicators of the systemic inflammatory response in the treatment of patients with gastrointestinal cancer. British Journal of Surgery 2013;100:1260-1. [DOI: 10.1002/bjs.9163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Kersten C, Louhimo J, Ålgars A, Lahdesmaki A, Cvancerova M, Stenstedt K, Haglund C, Gunnarsson U. Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Acta Oncol 2013;52:1691-8. [PMID: 24102179 DOI: 10.3109/0284186X.2013.835494] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
15 Shimazaki J, Tabuchi T, Nakachi T, Motohashi G, Nishida K, Ubukata H, Tabuchi T. Pre-operative granulocyte/lymphocyte ratio as a predictive marker of post-operative complications in patients with colorectal cancer. Oncol Lett 2015;9:425-9. [PMID: 25436003 DOI: 10.3892/ol.2014.2669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Yamamoto M, Saito H, Hara K, Sugezawa K, Uejima C, Tanio A, Tada Y, Kihara K, Sakamoto T, Honjo S, Fujiwara Y. Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer. In Vivo 2020;34:299-305. [PMID: 31882492 DOI: 10.21873/invivo.11774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Jiang H, Li H, Li A, Tang E, Xu D, Chen Y, Zhang Y, Tang M, Zhang Z, Deng X, Lin M. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget. 2016;7:72076-72083. [PMID: 27765916 DOI: 10.18632/oncotarget.12271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
18 Todinova S, Krumova S, Kurtev P, Dimitrov V, Djongov L, Dudunkov Z, Taneva SG. Calorimetry-based profiling of blood plasma from colorectal cancer patients. Biochimica et Biophysica Acta (BBA) - General Subjects 2012;1820:1879-85. [DOI: 10.1016/j.bbagen.2012.08.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
19 Lu X, Guo W, Xu W, Zhang X, Shi Z, Zheng L, Zhao W. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients. Cancer Manag Res. 2019;11:229-249. [PMID: 30636896 DOI: 10.2147/cmar.s185350] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
20 Borda F, Borda A, Jiménez J, Zozaya JM, Prieto C, Gómez M, Urman J, Ibáñez B. Valor predictivo de la hipoalbuminemia pre-tratamiento sobre el pronóstico del cáncer colorrectal resecado. Gastroenterología y Hepatología 2014;37:289-95. [DOI: 10.1016/j.gastrohep.2013.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bailon-Cuadrado M, Choolani-Bhojwani E, Tejero-Pintor FJ, Sanchez-Gonzalez J, Rodriguez-Lopez M, Perez-Saborido B, Marcos-Rodriguez JL. Preoperative platelet-lymphocyte ratio is an independent factor of poor prognosis after curative surgery for colon cancer. Updates Surg 2018;70:33-9. [PMID: 29222632 DOI: 10.1007/s13304-017-0503-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One 2015;10:e0143080. [PMID: 26717416 DOI: 10.1371/journal.pone.0143080] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 16.1] [Reference Citation Analysis]
23 Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today. 2015;45:315-321. [PMID: 24817059 DOI: 10.1007/s00595-014-0909-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
24 Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, Cassano A, Barone C. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? Clin Colorectal Cancer 2017;16:264-74. [PMID: 28412137 DOI: 10.1016/j.clcc.2017.03.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
25 Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer. Ann Surg Oncol. 2016;23:900-907. [PMID: 26530445 DOI: 10.1245/s10434-015-4948-7] [Cited by in Crossref: 103] [Cited by in F6Publishing: 114] [Article Influence: 14.7] [Reference Citation Analysis]
26 Bailon-Cuadrado M, Perez-Saborido B, Sanchez-Gonzalez J, Rodriguez-Lopez M, Mayo-Iscar A, Pacheco-Sanchez D. A new dimensional-reducing variable obtained from original inflammatory scores is highly associated to morbidity after curative surgery for colorectal cancer. Int J Colorectal Dis 2018;33:1225-34. [PMID: 29926232 DOI: 10.1007/s00384-018-3100-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Mori S, Kita J, Kato M, Shimoda M, Kubota K. Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy. Am J Surg 2015;209:187-93. [PMID: 24950991 DOI: 10.1016/j.amjsurg.2014.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
28 Neumeyer S, Hua X, Seibold P, Jansen L, Benner A, Burwinkel B, Halama N, Berndt SI, Phipps AI, Sakoda LC, Schoen RE, Slattery ML, Chan AT, Gala M, Joshi AD, Ogino S, Song M, Herpel E, Bläker H, Kloor M, Scherer D, Ulrich A, Ulrich CM, Win AK, Figueiredo JC, Hopper JL, Macrae F, Milne RL, Giles GG, Buchanan DD, Peters U, Hoffmeister M, Brenner H, Newcomb PA, Chang-Claude J. Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis. Cancer Epidemiol Biomarkers Prev 2020;29:2719-28. [PMID: 33008876 DOI: 10.1158/1055-9965.EPI-20-0714] [Reference Citation Analysis]